TY - JOUR T1 - SARS-CoV-2 in wastewater settled solids is associated with COVID-19 cases in a large urban sewershed JF - medRxiv DO - 10.1101/2020.09.14.20194472 SP - 2020.09.14.20194472 AU - Katherine E. Graham AU - Stephanie K. Loeb AU - Marlene K. Wolfe AU - David Catoe AU - Nasa Sinnott-Armstrong AU - Sooyeol Kim AU - Kevan M. Yamahara AU - Lauren M. Sassoubre AU - Lorelay M. Mendoza AU - Laura Roldan-Hernandez AU - Linlin Li AU - Krista R. Wigginton AU - Alexandria B. Boehm Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/15/2020.09.14.20194472.abstract N2 - Wastewater-based epidemiology (WBE) may be useful for informing public health response to viral diseases like COVID-19 caused by SARS-CoV-2. We quantified SARS-CoV-2 RNA in wastewater influent and primary settled solids in two wastewater treatment plants to inform the pre-analytical and analytical approaches, and to assess whether influent or solids harbored more viral targets. The primary settled solids samples resulted in higher SARS-CoV-2 detection frequencies than the corresponding influent samples. Likewise, SARS-CoV-2 RNA was more readily detected in solids using one-step digital droplet (dd)RT-PCR than with two-step RT-QPCR and two-step ddRT-PCR, likely owing to reduced inhibition with the one-step ddRT-PCR assay. We subsequently analyzed a longitudinal time series of 89 settled solids samples from a single plant for SARS-CoV-2 RNA as well as coronavirus recovery (bovine coronavirus) and fecal strength (pepper mild mottle virus, PMMoV) controls. SARS-CoV-2 RNA targets N1 and N2 concentrations correlate positively and significantly with COVID-19 clinical confirmed case counts in the sewershed. Together, the results demonstrate that measuring SARS-CoV-2 RNA concentrations in settled solids may be a more sensitive approach than measuring SARs-CoV-2 in influent.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially supported by NSF RAPID (CBET-2023057) grant to KW and AB.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB approval needed for this work. No human subjects data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available for the work by contacting authors. ER -